The Therapeutic Goods Administration is experiencing system issues linked to global Microsoft outages. Some services may be disrupted and we may take longer to respond to email and phone contact during this time.

OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1mg/mL pump actuated metered dose aerosol (reformulation) (142197)

ARTG ID 142197

ARTG Name

OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1mg/mL pump actuated metered dose aerosol (reformulation)

Product name

OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1mg/mL pump actuated metered dose aerosol (reformulation)

ARTG Date

16 July 2007

Registration Type

Medicine

Therapeutic good type

Medicines

Ingredients

xylometazoline hydrochloride

Licence category

RE

Licence status

A

Summary

OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1mg/mL pump actuated metered dose aerosol (reformulation)(142197)-Summary-[PDF]

Related information

OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1 mg/mL pump actuated metered dose aerosol (reformulation), GlaxoSmithKline Consumer Healthcare Australia Pty Ltd, CON-885

25 November 2021

Section 14 consent

Consent to Import and supply while noncompliant with standards. The consent is effective from 25 November 2021 until 26 November 2023.
OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1mg/mL pump actuated metered dose aerosol (reformulation), Haleon Australia Pty Ltd, CON-1103

4 May 2023

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 4 May 2023 until 30 November 2025.